- Moody's•4 hours ago
Moody's: Outlook for global pharmaceuticals industry stable on low earnings growth, new product launches
Announcement: Moody's: Outlook for global pharmaceuticals industry stable on low earnings growth, new product launches. Global Credit Research- 26 Apr 2017. New York, April 26, 2017-- The outlook for the ...
- TheStreet.com•22 hours ago
K-Mart will charge cash paying customers $199 for a two-pack vs. Mylan's $643.
- Business Wire•yesterday
New Data Suggest Positive Effects of Sanofi Genzyme’s Aubagio® (teriflunomide) on Cortical Gray Matter Atrophy
Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today that new investigational data evaluating the effect of Aubagio® on cortical gray matter atrophy in patients with a first clinical episode suggestive of MS will be presented at the 69th American Academy of Neurology Annual Meeting.
SAN.PA : Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||84.48 - 85.18|
|52 Week Range||62.50 - 86.05|
|PE Ratio (TTM)||23.35|
|Dividend & Yield||3.35 (3.72%)|
|1y Target Est||N/A|